The therapy, dubbed OST-HER2, uses a HER2-bioengineered form of the bacteria Listeria monocytogenes to trigger an immune ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Medically reviewed by Marla Anderson, MD The first signs of metastatic breast cancer depend on where the cancer spreads from ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.

The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease progression/death by 37% vs ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...

A recent study has highlighted a significant increase in the use of inpatient palliative care among metastatic testicular cancer patients undergoing critical care therapy between 2008 and 2019. Read ...

Researchers identify distinct molecular and immune profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma.

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.